Mechanistically, ESR1 deficiency has been identified by RNA sequencing and bioinformatic analysis to play a key role in psoriasis development and relapse, which, attractively, could be inhibited to large extents by FeN4O2-SACs treatment via ESR1 upregulation. This evidence concerns the gene ESR1 and psoriasis.